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Antimicrobial resistance—a threat to neonate survival
Improvements in child survival have contributed much 
of the gains in life expectancy at birth during the last 
two decades. At a global level, neonatal mortality has 
decreased from 36 to 19 deaths per 1000 livebirths 
between 1990 and 2012.1 However, the reduction in 
neonatal mortality between 1990 and 2015 (47%) 
has lagged behind that of postneonatal under-5 years 
mortality (58%) globally.2 The Every Newborn Action 
Plan aims for countries to have ten or fewer neonatal 
deaths per 1000 livebirths by 2035 (or 12 or fewer 
neonatal deaths by 2030).3  
40% of newborn deaths and stillbirths occur around 
the time of birth and interventions that focus on 
facility-based care during this period have been shown 
to eﬀ ectively prevent deaths and disability.4 A particular 
focus of these interventions is on the reduction of 
neonatal sepsis or meningitis, which accounted for 
421 000 deaths5 or roughly 16% of neonatal deaths 
in 2013,5 in which rates of reduction between 1990 
and 2012 have been among the slowest. Facility-
based births could help to reduce the risk of sepsis 
but poor quality facilities are where the dangers of 
antimicrobial resistance are greatest. Estimates indicate 
that 56 524 neonates die each year from resistance-
attributable neonatal sepsis deaths caused by bacteria 
resistant to ﬁ rst-line antibiotics in India; the toll in 
Pakistan is 25 692 neonates.6 
Our understanding of the impact of antimicrobial 
resistance on sepsis outcomes comes from small single-
centre studies. In Tanzania, 40% of the 300 neonates 
with sepsis at a neonatal unit tracked in one study 
had early onset sepsis and 47% had a positive blood 
culture.7 Of those, 29% of neonates who were culture 
positive died compared with 9% who were culture 
negative. Mortality was increased in neonates with a 
Gram-negative bacterial infection, extended-spectrum 
β lactamase producing organism or meticillin-resistant 
Staphylococcus aureus. A single neonatal intensive care 
unit study from India reported that the proportion 
of culture positive sepsis was 14·8 per 1000 inborn 
neonates and 83·0 per 1000 outborn neonates based 
on 997 blood cultures. Overall sepsis-related mortality 
was 19%.8 Most cultures showed Gram-negative 
bacteria, Klebsiella pneumoniae being the most common 
pathogen.
The Delhi Neonatal Infection Study (DeNIS)9 followed 
up a cohort of 88 636 newborn infants for about 3 years 
in three large hospitals in Delhi, India, and represents 
one of the largest studies to date of neonatal sepsis 
and resistance in the Indian subcontinent. A few key 
results stand out. Rates of culture-proven sepsis were 
high—9·5 per 1000 livebirths compared with less than 
5·0 per 1000 livebirths in high-income countries10 but 
lower than the 15·6 per 1000 livebirths reported from 
the National Neonatal-Perinatal Database of India.8 
Early onset sepsis was common with nearly two-thirds 
of cases occurring within 72 h of birth. Three pathogens 
(Klebsiella spp, Acinetobacter spp, and Escherichia coli) 
were associated with more than half (53%) of the 
infections. 181 (82%) of 222 infections caused by 
Acinetobacter spp were multidrug resistant, conﬁ rming 
that pan-resistant untreatable Acinetobacter spp 
infections associated with high mortality in neonatal 
nurseries is a subcontinentinal-wide problem.11 Sepsis 
accounted for nearly a quarter of all newborn deaths, 
higher than the 15% in global estimates noted in 2013.5 
Case fatality rates of culture-positive and culture-
negative sepsis were similar to those observed in other 
low-income and middle-income country settings 
(ﬁ gure 1). 
Figure: Case fatality rates from the DeNIS study (unshaded) compared with earlier studies (in solid colours)
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There was a modest excess risk of mortality associated 
with multidrug-resistant organisms, which was lower 
than that previously recorded in south Asia.18 There 
are methodological challenges in the attribution of 
excess neonatal mortality with antimicrobial resistance 
because of known confounding with severity of illness 
at presentation, treatment delay, and antibiotic choices. 
The fairly modest excess mortality (signiﬁ cant only for 
Acinetobacter spp and Pseudomonas spp) associated with 
antimicrobial resistance is also possibly accounted for 
by the high baseline mortality associated with culture-
positive sepsis—as high as 67% in one facility.  
Resistance among hospital acquired infections in 
Indian hospitals is a growing problem and driven by 
a combination of poor infection control and high, 
uncontrolled rates of antimicrobial prescribing.19 Many 
neonates in hospitals in south Asia are now treated with 
carbapenems as a ﬁ rst-line therapy for sepsis or presumed 
sepsis. Against this backdrop, the widespread availability 
and antimicrobial use in community settings and the 
contribution of antimicrobial resistance as a complicating 
factor in neonate sepsis becomes extremely important.  
Notwithstanding the importance of preventive 
strategies to reduce the risks and burden of neonatal 
infections,3 early detection and prescribing of appropriate 
antibiotics will remain the cornerstone of management 
strategies. The DeNIS study highlights the serious 
risk associated with neonatal sepsis and resistance in 
health-care facilities that would rank among the better 
 performing hospitals in a large middle-income country.
With an increased focus on institutionalising births 
in India and other low-income and middle-income 
countries, the quality of care and infection control in 
health-care institutions must receive greater attention 
and resources.
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